Genomenon, Inc
Genomenon is a genomic intelligence company that provides software and services to enhance clinical diagnostics and support pharmaceutical research. They offer platforms like the Mastermind Genomic Intelligence Platform and Cancer Knowledgebase, which help clinicians and researchers interpret genomic data. Their customers include pharmaceutical companies and clinical labs seeking to improve patient outcomes through better genomic insights. Genomenon operates from Ann Arbor, Michigan.
Headcount
Website visitors
Workforce
Headcount by location
- United States58%
- Bosnia and Herzegovina42%
Split by department
- Engineering & R&D49%
- Healthcare8.2%
- Founder, Owner & Executive4.9%
- Marketing & Comms4.9%
- Other33%
Seniority distribution
- Less than 5 years69%
- 5 to 10 years22%
- 10 to 20 years6.6%
- 30 years and more1.7%
- 20 to 30 years0.8%
Funding
Raised to date
- 15 Jul 2026Undefined Funding$6.0MBeringea
- 1 May 2024Undefined Funding$5.5MBeringea
7 earlier rounds, with their terms and sources.
Investors
The National Institutes of HealthThe National Institutes of Health (NIH) is a public entity and the United States' primary medical research agency. It funds biomedical research through grants, conducts its own research, and provides health information via the National Library of1,874United States
University of MichiganThe University of Michigan is a public entity that provides a comprehensive range of educational programs and services. It serves a diverse community of students, faculty, and staff, offering undergraduate and graduate degrees, research244United States
Michigan RiseMichigan Rise Pre-Seed Fund III is a not-for-profit venture capital firm that supports the growth of Michigan-based technology startups through early-stage funding and strategic guidance. The organization focuses on connecting startups with141United States
BeringeaBeringea is a venture capital firm that specializes in providing investment and support to rapidly scaling entrepreneurial companies. They focus on offering capital and strategic guidance to businesses across various sectors, helping them navigate121United States
Portfolio
Countries
- United States100%
Deal stage
- Asset Acquisition67%
- Company Acquisition33%
Deal size
- Unknown100%
Company size
- Unknown100%
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- ACMG 2026: the evidence problem holding back rare disease diagnosis.attends event
- Genomenon Announces Participation in BIO Partnering(TM)@JPM Week 2026attends event
- Genomenon Appoints Kristin Fix as Senior Vice President of Sales, Strengthening Focus on Literature-Derived Real-World Evidencehires
- AMP 2025 Recap: Genomenon Highlights from the Annual Meetingattends event
Portfolio companies
Every holding by name, with what was paid, when, and how each one has grown since
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Genomenon, Inc profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.